145-23 (Rollover)
ClinicalTrials.gov NCT02711852
Research payments
$66,182
Through program year 2020, $66,182 in research payments was reported against 145-23 (Rollover), across 16 payments, paid by Verastem, Inc..
- Paid by
- Verastem, Inc.
- ClinicalTrials.gov
- NCT02711852
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $66,182 | 16 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
3 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.